http://blog.pharmtech.com/2011/11/04/sanofi-could-be-top-by-2012/ The blog of Pharmaceutical Technology magazine Thu, 09 May 2013 23:30:55 -0400 http://wordpress.org/?v=2.8.4 hourly 1 http://blog.pharmtech.com/2011/11/04/sanofi-could-be-top-by-2012/comment-page-1/#comment-41736 Stephanie Sutton, PharmTech Europe Fri, 11 Nov 2011 15:58:40 +0000 http://blog.pharmtech.com/?p=4910#comment-41736 Quite right. Price now amended. Quite right. Price now amended.

]]> http://blog.pharmtech.com/2011/11/04/sanofi-could-be-top-by-2012/comment-page-1/#comment-41716 Mike Doucette Thu, 10 Nov 2011 19:01:38 +0000 http://blog.pharmtech.com/?p=4910#comment-41716 Genzyme price was $20B, not $200B. Genzyme price was $20B, not $200B.

]]>